These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 10362361

  • 1. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
    Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP.
    Oncogene; 1999 Jun 03; 18(22):3399-406. PubMed ID: 10362361
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 2000 Jun 03; 41(7):1885-93. PubMed ID: 10845613
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G.
    J Neurosci Res; 2003 Dec 01; 74(5):760-8. PubMed ID: 14635227
    [Abstract] [Full Text] [Related]

  • 4. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
    Nakamura T, Kanda S, Yamamoto K, Kohno T, Maeda K, Matsuyama T, Kanetake H.
    Oncogene; 2001 Nov 15; 20(52):7610-23. PubMed ID: 11753639
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 6. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM.
    EXS; 1993 Feb 07; 65():131-65. PubMed ID: 8380735
    [Abstract] [Full Text] [Related]

  • 7. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering.
    Tanimura S, Chatani Y, Hoshino R, Sato M, Watanabe S, Kataoka T, Nakamura T, Kohno M.
    Oncogene; 1998 Jul 09; 17(1):57-65. PubMed ID: 9671314
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2.
    Tacchini L, Dansi P, Matteucci E, Desiderio MA.
    Exp Cell Res; 2000 Apr 10; 256(1):272-81. PubMed ID: 10739674
    [Abstract] [Full Text] [Related]

  • 10. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K, Tanaka S.
    Mol Cancer Res; 2006 Jul 10; 4(7):499-510. PubMed ID: 16849525
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A, Götze T, Korc M.
    Cancer Res; 2007 Nov 01; 67(21):10309-16. PubMed ID: 17974973
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R, Soriano JV, Malinda KM, Ponce ML, Bafico A, Kleinman HK, Bottaro DP, Aaronson SA.
    Cell Growth Differ; 1998 May 01; 9(5):355-65. PubMed ID: 9607557
    [Abstract] [Full Text] [Related]

  • 13. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb 01; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 14. beta-Catenin and actin reorganization in HGF/SF response of ST14A cells.
    Soldati C, Biagioni S, Poiana G, Augusti-Tocco G.
    J Neurosci Res; 2008 Apr 01; 86(5):1044-52. PubMed ID: 17975841
    [Abstract] [Full Text] [Related]

  • 15. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W.
    Oncogene; 1992 Nov 01; 7(11):2195-206. PubMed ID: 1331934
    [Abstract] [Full Text] [Related]

  • 16. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP.
    Oncogene; 2002 Mar 28; 21(14):2201-11. PubMed ID: 11948403
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.
    Oncogene; 2002 Apr 04; 21(15):2309-19. PubMed ID: 11948414
    [Abstract] [Full Text] [Related]

  • 18. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R.
    Clin Cancer Res; 2002 Feb 15; 8(2):620-7. PubMed ID: 11839685
    [Abstract] [Full Text] [Related]

  • 20. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, Christensen JG, Waage A, Sundan A, Børset M.
    Clin Cancer Res; 2004 Oct 01; 10(19):6686-94. PubMed ID: 15475459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.